Rémi Vergara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rémi Vergara has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Anne Rullier
Laboratoire d'anatomie et cytologie pathologiques, CHU de Bordeaux, Bordeaux, France
3 shared publicationsIvan Théate
Service d'anatomie pathologique, CHU d'UCL Namur (site Godinne), Namur, Belgique
3 shared publications- Anne Rullier
Service de Pathologie, Place Amélie Rabat-Léon, CHU Bordeaux, Bordeaux, France
2 shared publications Brigitte Le Bail
BRIC (BoRdeaux Institute of onCology), University of Bordeaux, Bordeaux, France
2 shared publicationsBéatrice Vergier
Department of Pathology, Bordeaux University Hospital, Bordeaux, France
2 shared publicationsCaroline Dutriaux
BoRdeaux Institute of onCology (BRIC), UMR 1312 INSERM University of Bordeaux, Bordeaux, France
2 shared publications
Latest Publications
- Open Access
- 3 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Improving diagnostic accuracy in atypical melanocytic tumors using p16 immunohistochemistry and 9p21 fluorescence in situ hybridization: analysis of 206 second opinion cases
Diagnosing atypical melanocytic tumors can be challenging without molecular characterization, necessitating simple tools to enhance diagnostic accuracy in daily practice. This study retrospectively analyzed the utility of p16 immunohistochemistry (IHC) and 9p21 fluorescence in situ hybridization (FISH) on 206 tumors referred for expert second opinion. The performance of p16 and 9p21 was compared to histological diagnosis (both initial and final respectively without and with p16 and 9p21 status), histological subtype, and follow-up data. Negative p16 immunolabelling detected 90% of malignant cases, while only 11% of benign tumors were p16 negative. Homozygous 9p21deletion detected 42% of malignant tumors and excluded 95% of benign ones. Heterozygous deletion showed no diagnostic value. Homozygous 9p21 deletion significantly improved diagnostic confidence (P < 0.001), leading to tumor upgrading (n = 23) or melanoma confirmation (n = 22). Among 97 patients with follow-up, 17 had adverse outcomes. Kaplan–Meier analysis showed no significant difference in progression-free survival between groups (P = 0.64). Combining both techniques ultimately enhanced histological diagnostic confidence in daily practice. However, in cases where p16 is negative without homozygous deletion, or where histological malignancy is uncertain and p16 positive, other p16-inactivation mechanisms or molecular anomalies should be considered, necessitating further molecular investigations.
- 3 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Open AccessImproving diagnostic accuracy in atypical melanocytic tumors using p16 immunohistochemistry and 9p21 fluorescence in situ hybridization: analysis of 206 second opinion cases
Diagnosing atypical melanocytic tumors can be challenging without molecular characterization, necessitating simple tools to enhance diagnostic accuracy in daily practice. This study retrospectively analyzed the utility of p16 immunohistochemistry (IHC) and 9p21 fluorescence in situ hybridization (FISH) on 206 tumors referred for expert second opinion. The performance of p16 and 9p21 was compared to histological diagnosis (both initial and final respectively without and with p16 and 9p21 status), histological subtype, and follow-up data. Negative p16 immunolabelling detected 90% of malignant cases, while only 11% of benign tumors were p16 negative. Homozygous 9p21deletion detected 42% of malignant tumors and excluded 95% of benign ones. Heterozygous deletion showed no diagnostic value. Homozygous 9p21 deletion significantly improved diagnostic confidence (P < 0.001), leading to tumor upgrading (n = 23) or melanoma confirmation (n = 22). Among 97 patients with follow-up, 17 had adverse outcomes. Kaplan–Meier analysis showed no significant difference in progression-free survival between groups (P = 0.64). Combining both techniques ultimately enhanced histological diagnostic confidence in daily practice. However, in cases where p16 is negative without homozygous deletion, or where histological malignancy is uncertain and p16 positive, other p16-inactivation mechanisms or molecular anomalies should be considered, necessitating further molecular investigations.
- Open Access
Recycled formalin: a new tool to mitigate the environmental impact of surgical pathology in routine practice
- 5 December 2024
- Published by BMJ in Journal of Clinical Pathology
- Vol. 78 (4) , 233-239
Surgical pathology and sustainable development: international landscape and prospects
The healthcare sector significantly contributes to global greenhouse gas emissions, with surgical pathology (SP) playing a notable role. This review explores the ecological transformation of SP, offering a global overview of existing challenges and sustainable initiatives worldwide. While some countries, such as the UK and France, have developed national strategies to reduce the carbon footprint of healthcare, including SP, many regions remain at an early stage of implementing green practices. Several studies have assessed the carbon footprint of SP, focusing on key aspects such as laboratory operations, pathology procedures and functional units, highlighting materials and transportation as major contributors to emissions. The integration of digital pathology and artificial intelligence (AI) presents opportunities to enhance efficiency and address medical deserts but also poses challenges due to the associated energy consumption. Local initiatives such as the ‘Transformation Ecologique en Anatomie et Cytologie Pathologiques’ (Ecological transformation in SP) or TEAP collective in France, Belgium’s ‘Green Team’ and sustainable practices in Tunisia and New Zealand demonstrate the global effort to reduce the environmental impact of SP. Key strategies discussed include ecodesign of care, circular economy practices, green AI and partnerships with industry. However, achieving meaningful reductions in SP’s environmental impact requires international cooperation and support from national health policies. This review emphasises the importance of collaborative efforts to implement sustainable solutions without compromising the quality and safety of healthcare services.
- 5 December 2024
- Published by BMJ in Journal of Clinical Pathology
- Vol. 78 (4) , 233-239
Surgical pathology and sustainable development: international landscape and prospects
The healthcare sector significantly contributes to global greenhouse gas emissions, with surgical pathology (SP) playing a notable role. This review explores the ecological transformation of SP, offering a global overview of existing challenges and sustainable initiatives worldwide. While some countries, such as the UK and France, have developed national strategies to reduce the carbon footprint of healthcare, including SP, many regions remain at an early stage of implementing green practices. Several studies have assessed the carbon footprint of SP, focusing on key aspects such as laboratory operations, pathology procedures and functional units, highlighting materials and transportation as major contributors to emissions. The integration of digital pathology and artificial intelligence (AI) presents opportunities to enhance efficiency and address medical deserts but also poses challenges due to the associated energy consumption. Local initiatives such as the ‘Transformation Ecologique en Anatomie et Cytologie Pathologiques’ (Ecological transformation in SP) or TEAP collective in France, Belgium’s ‘Green Team’ and sustainable practices in Tunisia and New Zealand demonstrate the global effort to reduce the environmental impact of SP. Key strategies discussed include ecodesign of care, circular economy practices, green AI and partnerships with industry. However, achieving meaningful reductions in SP’s environmental impact requires international cooperation and support from national health policies. This review emphasises the importance of collaborative efforts to implement sustainable solutions without compromising the quality and safety of healthcare services.
- Open Access
- 4 December 2024
- Published by Wiley in Histopathology
- Vol. 86 (5) , 704-714
Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients
Aims: Primary cutaneous marginal zone lymphoma (PCMZL) is considered a lymphoproliferative disorder (International Consensus Classification, ICC) or an overt lymphoma (WHO‐HAEM5). Seeking evidence for a reactive process or true lymphoma, we retrieved recurrent PCMZLs from the French Study Group of Cutaneous Lymphoma (GFELC) database.Methods: Histology, phenotype (light‐chain restriction, immunoglobulin, and immune‐receptor translocation‐associated protein‐1 [IRTA1] expression) and B‐cell clonality at diagnosis and recurrence were compared according to recurrence site (local, locoregional, or distant) and outcomes.Results: Initial lesions of the 61 patients (mean age 52) were mostly isolated on the trunk (48%) and classified T1 (70%). Times to first recurrence for local, locoregional, and distant recurrences, were 20, 29, and 37 months, respectively. Light‐chain restriction type did not differ significantly between local/locoregional recurrences and distal recurrences (P = 0.06; n = 60). The same B‐cell clones were identified for 23/42 local/locoregional recurrences, while 5/19 distant recurrences showed different clonal profiles (P = 0.0003). No tumour expressed IRTA1. Fifty‐eight tumours were heavy‐chain (IgG/IgG4) class‐switched PCMZLs and 3 IgM+/IgD– PCMZLs. All IgM+ tumours underwent either transformation (skin or brain) into diffuse large B‐cell lymphomas (DLBCLs) and extracutaneous spreading.Conclusion: As suggested by WHO‐HAEM5, immunoglobulin phenotype assessment (IgM alongside IgD) appears to be a possible valuable tool in the initial diagnosis of PCMZL to differentiate between the indolent class‐switched PCMZL (IgM‐negative) and IgM+ (IgD–) PCMZL, which has an uncertain prognosis. The variation in B‐cell rearrangements and light chain restriction observed in distant recurrences of PCMZL may suggest different antigen‐driven stimulation processes.
- 4 December 2024
- Published by Wiley in Histopathology
- Vol. 86 (5) , 704-714
Open AccessRecurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients
Aims: Primary cutaneous marginal zone lymphoma (PCMZL) is considered a lymphoproliferative disorder (International Consensus Classification, ICC) or an overt lymphoma (WHO‐HAEM5). Seeking evidence for a reactive process or true lymphoma, we retrieved recurrent PCMZLs from the French Study Group of Cutaneous Lymphoma (GFELC) database.Methods: Histology, phenotype (light‐chain restriction, immunoglobulin, and immune‐receptor translocation‐associated protein‐1 [IRTA1] expression) and B‐cell clonality at diagnosis and recurrence were compared according to recurrence site (local, locoregional, or distant) and outcomes.Results: Initial lesions of the 61 patients (mean age 52) were mostly isolated on the trunk (48%) and classified T1 (70%). Times to first recurrence for local, locoregional, and distant recurrences, were 20, 29, and 37 months, respectively. Light‐chain restriction type did not differ significantly between local/locoregional recurrences and distal recurrences (P = 0.06; n = 60). The same B‐cell clones were identified for 23/42 local/locoregional recurrences, while 5/19 distant recurrences showed different clonal profiles (P = 0.0003). No tumour expressed IRTA1. Fifty‐eight tumours were heavy‐chain (IgG/IgG4) class‐switched PCMZLs and 3 IgM+/IgD– PCMZLs. All IgM+ tumours underwent either transformation (skin or brain) into diffuse large B‐cell lymphomas (DLBCLs) and extracutaneous spreading.Conclusion: As suggested by WHO‐HAEM5, immunoglobulin phenotype assessment (IgM alongside IgD) appears to be a possible valuable tool in the initial diagnosis of PCMZL to differentiate between the indolent class‐switched PCMZL (IgM‐negative) and IgM+ (IgD–) PCMZL, which has an uncertain prognosis. The variation in B‐cell rearrangements and light chain restriction observed in distant recurrences of PCMZL may suggest different antigen‐driven stimulation processes.
- 24 August 2024
- Published by Elsevier in Annales de Pathologie
- Vol. 44 (5) , 338-345
Face au changement climatique, un écosoin pertinent et sobre en anatomo-pathologie en France est-il possible ?
- 24 August 2024
- Published by Elsevier in Annales de Pathologie
- Vol. 44 (5) , 338-345
Face au changement climatique, un écosoin pertinent et sobre en anatomo-pathologie en France est-il possible ?
- 3 July 2024
- Published by Elsevier in Annales de Pathologie
- Vol. 44 (5) , 346-352
Le formol recyclé : un nouvel outil d’atténuation de l’impact environnemental de l’ACP ?
- 3 July 2024
- Published by Elsevier in Annales de Pathologie
- Vol. 44 (5) , 346-352
Le formol recyclé : un nouvel outil d’atténuation de l’impact environnemental de l’ACP ?
- 10 May 2024
- Published by Springer Nature in Virchows Archiv
- Vol. 486 (2) , 225-231
Reducing reflex first-line prescriptions in a surgical pathology laboratory: toward sustainable practice with positive economic and clinical effects
In surgical pathology departments, reflex first-line techniques (RFLTs) are aimed at reducing workloads and addressing recent shortages of medical personnel. However, the impacts thereof on economic and diagnostic factors have been poorly addressed. Also, in the era of global warming, environmental considerations are crucial. This study assessed the economic and diagnostic efficacies of routine pathological RFLT and the quality of care and sustainability. Ten RFLTs of the Bordeaux University Hospital pathology department (six special stains, one cytology technique, and three immunohistochemical tests) were studied. First, a retrospective economic analysis evaluated the average cost of these RFLTs per slide and per year. Second, diagnostic relevance was prospectively surveyed. Third, the effects of changes made were analyzed over 2 years. The ten RFLTs were associated with average annual costs of €46,708. Diagnostic relevance analysis indicated that most stains were unnecessary; only 17% were requested as second-line techniques. Elimination of 7/10 tests afforded annual cost savings of €22,522 and reduced the workload by 5568 tests/year, without compromising the workflow or diagnostic quality. Seven of ten RFLTs could be eliminated without compromising diagnostic quality or the workflow. This afforded not only financial benefits but also positive social and environmental impacts. We offer valuable insights into appropriate practices in surgical pathology laboratories. Collaboration between the medical and technical teams was crucial; other healthcare sectors would also benefit from our approach.
- 10 May 2024
- Published by Springer Nature in Virchows Archiv
- Vol. 486 (2) , 225-231
Reducing reflex first-line prescriptions in a surgical pathology laboratory: toward sustainable practice with positive economic and clinical effects
In surgical pathology departments, reflex first-line techniques (RFLTs) are aimed at reducing workloads and addressing recent shortages of medical personnel. However, the impacts thereof on economic and diagnostic factors have been poorly addressed. Also, in the era of global warming, environmental considerations are crucial. This study assessed the economic and diagnostic efficacies of routine pathological RFLT and the quality of care and sustainability. Ten RFLTs of the Bordeaux University Hospital pathology department (six special stains, one cytology technique, and three immunohistochemical tests) were studied. First, a retrospective economic analysis evaluated the average cost of these RFLTs per slide and per year. Second, diagnostic relevance was prospectively surveyed. Third, the effects of changes made were analyzed over 2 years. The ten RFLTs were associated with average annual costs of €46,708. Diagnostic relevance analysis indicated that most stains were unnecessary; only 17% were requested as second-line techniques. Elimination of 7/10 tests afforded annual cost savings of €22,522 and reduced the workload by 5568 tests/year, without compromising the workflow or diagnostic quality. Seven of ten RFLTs could be eliminated without compromising diagnostic quality or the workflow. This afforded not only financial benefits but also positive social and environmental impacts. We offer valuable insights into appropriate practices in surgical pathology laboratories. Collaboration between the medical and technical teams was crucial; other healthcare sectors would also benefit from our approach.